NanoViricides Inc (NYSE American:NNVC)
| 1.06 Delayed Data As of May 31 |  -0.02 / -1.85%Today’s Change | 1.04 Today|||52-Week Range 3.88 | -4.50% Year-to-Date |
Latest NNVC News | Press Releases
No recent news for NanoViricides Inc.
Today’s Trading
| Previous close | 1.08 |
| Today’s open | 1.08 |
| Day’s range | 1.06 - 1.10 |
| Volume | 8,436 |
| Average volume (3 months) | 37,157 |
| Market cap | $12.8M |
Data as of 2:55pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | +13.16% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRVNTrevena Inc | -0.02 | -1.72% |
| SXTCChina SXT Pharmaceut... | -0.00 | -0.64% |
| JAGXJaguar Health Inc | -0.02 | -2.90% |
| APMAptorum Group Ltd | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/31/2023
Financials
| Last reporting date | May 31, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$8.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Shelton, Connecticut |
Forecasts
